Tom Chittenden, PhD, DPhil, PStat

Chief Technology Officer

“What we are working towards is that the application of these technologies will lead to the eradication of human disease. “

Dr. Tom Chittenden is Chief Technology Officer for Genuity Science. He is also the President and and is responsible for global AI/ML R&D.

Tom is an Omega Society Fellow and an Accredited Professional Statistician™ with the American Statistical Association. He holds faculty appointments at Boston Children’s Hospital and the Harvard Medical School. His research has been published in top-tier scientific journals, including featured articles in Nature and Science.  In 2019, Forbes named him among the top 100 AI Pioneers in Drug Discovery and Advanced Healthcare. In 2021, he was named the Business Intelligence Group (BIG) AI Excellence Award Winner. Tom was also the recipient of the 2021 Global Genius Directory Award in recognition of his contribution to cognitive science and artificial intelligence. In October 2021, Dr. Chittenden earned full membership in the United Giga Society, a six-sigma high-IQ society requiring a qualifying score of IQ ≥ 190 (SD15) on a high-range test of general intelligence. Tom is regarded as one of the world’s leading authorities on AI and causal statistical machine learning in the biomedical sciences.

Tom holds a PhD in Molecular Cell Biology and Biotechnology from Virginia Tech and a DPhil in Computational Statistics from the University of Oxford. His multidisciplinary postdoctoral training includes experimental investigations in Molecular and Cellular Cardiology from the Dartmouth Medical School; Biostatistics and Computational Biology from the Dana‐Farber Cancer Institute and the Harvard School of Public Health; and Computational Statistics, Statistical Methodology, and Statistical Machine Learning from the University of Oxford.